Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Rvirogen Logo
Rvirogen Growth Score
66
CB Rank
58802
Heat Score
84
Rvirogen is a biotechnology company that offers cancer treatment using viruses without side effects via therapies and medications.
Founded
obfuscation
PrivateSeed Minato, Chiba, Japan1-10 www.rvirogen.com/
Alternative Medicine
Biotechnology
Pharmaceutical
Therapeutics
Overview

Rvirogen
Total Funding
obfuscation
Growth Score
66
Heat Score
84

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score66
-2 pts
in past quarter
Heat Score 84
23 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Rvirogen

CB Rank
58802
Rvirogen is a biotechnology company that offers cancer treatment using viruses without side effects via therapies and medications.
Founded
obfuscation
PrivateSeed Minato, Chiba, Japan1-10 www.rvirogen.com/
Alternative Medicine
Biotechnology
Pharmaceutical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Rvirogen Inc.
Also Known As アールバイロジェン
Operating Status Active
Company Type For Profit
About the Company
Rvirogen is a biotech business that aims to provide cancer treatment with an oncolytic virus. The company offers virus-based cancer treatments, therapies, and medicines, allowing health professionals to treat cancer without side effects.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Panectin
A genetically modified measles virus designed to selectively replicate in and kill cancer cells without harming normal cells, used for oncolytic virotherapy.
Oncolytic Virotherapy
A cancer treatment using genetically modified viruses that selectively replicate in and kill cancer cells while activating the immune system.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed
obfuscation
Seed Round - Rvirogen Logo
Seed Round - Rvirogen
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

648

Active Website Tech Count

2Rvirogen is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Rvirogen's headquarters? Rvirogen is located in Minato, Chiba, Japan.When was the last funding round for Rvirogen? Rvirogen closed its last funding round on
obfuscation
from a Seed round.Who are Rvirogen's competitors? Alternatives and possible competitors to Rvirogen may include Vyriad, CG Oncology, and  Turnstone Biologics.How much funding has Rvirogen raised to date? Rvirogen has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(0deebd1 1)
|